Engineering the Therapeutics of the Future

Co-Located with Molecular Med TRI-CON Asia

May 28-31, 2013
Marina Bay Sands, Singapore

Molecular Medicine Tri-Conference Asia 2013

Speaker List

 

  • Dana Ault-Riche, Ph.D., CEO, Pharmaceuticals, Reflexion Pharmaceuticals
  • Satoshi Banba, Executive Director, Medical & BioTechnology Department, Seed Planning, Inc.
  • John Dangerfield, Ph.D., Managing Director, Anovasia Pte Ltd
  • Dimiter Dimitrov, Ph.D., Senior Investigator, Center for Cancer Research, National Cancer Institute, NIH
  • Bogi Eliasen, Program Director, FarGen, Ministry of Health, Faroe Islands
  • Andrew Fellowes, Ph.D.,  FHGSA, FFSc(RCPA), Scientist in Charge, Molecular Pathology Diagnostic Development, Peter MacCallum Cancer Centre
  • Mick Foley, Ph.D., CSO, AdAlta Pty Ltd.
  • Samik Ghosh, Ph.D., Senior Scientist, The Systems Biology Institute, Tokyo
  • Rui Gong, Ph.D., Professor, Head, Antibody Engineering Group, Wuhan Institute of Virology, Chinese Academy of Sciences, China
  • Professor Y.K. Gupta, M.D., FAMS, FNASc, FIPS, FIAN, FST, FIACS, Chairman, Department of Pharmacology, National Scientific Coordinator, Pharmacovigilance Program of India; President, Society of Toxicology, India
  • Ryo Hamada, Ph.D., Panasonic Healthcare Co., Ltd.
  • Clive Higgins, Vice President, Marketing, Informatics, PerkinElmer
  • Catherine Hutchings, Ph.D., Principal Scientist, Antibody Discovery & Strategy Partnering, Heptares Therapeutics Ltd.
  • Toshihisa Ishikawa, Ph.D., Professor of Biochemistry, Molecular Biology, and Pharmacogenomics, Omics Science Center, RIKEN Yokohama Institute
  • Sanjay Joshi, CTO, EMC Isilon Storage Division
  • Sanjay K. Kakkar, Ph.D., MBBS, M.Sc., M.P.H., Chairman and Founder, Jai Medica Pvt. Ltd. (Jai Health)
  • Sanjay Khare, Ph.D., CEO and President, ImmunGene, Inc.
  • Sir David Lane, Ph.D., Professor & Chief Scientist, A*STAR; Director, p53 Laboratory
  • Jimmy Lin, M.D., Ph.D., MHS, Founder and President, Rare Genomics Institute; Research Instructor, Washington University St. Louis
  • Hendrick Loei, Field Application Specialist (SEA), ForteBio, A Division of Pall Life Sciences
  • Ying Luo, Ph.D., Chairman, President and CEO, Shanghai Genomics, Inc.; Chairman, Beijing Continent Pharmaceuticals, Inc. 
  • Paul A. Macary, Ph.D., Assistant Professor, Department of Microbiology, National University of Singapore
  • Stephen Mahler, Ph.D., Professor, Head of Discipline Chemical and Biological Engineering, Australian Institute for Bioengineering and Nanotechnology
  • Sanjay Navani, M.D., Surgical Pathologist and Immunohistochemist, LAB SURGPATH; Site Director, The Human Protein Atlas (HPA) Project
  • Junichi Nezu, Ph.D., Research Head, Chugai Pharmabody Research Pte. Ltd. Singapore
  • Stephen J. O'Brien, Ph.D., Chief Scientific Officer, Theodosius Dobzhansky Center for Genome Bioinformatics, St. Petersburg  State University
  • Arvind Rajpal, Ph.D., Vice President, Protein Engineering, Rinat-Pfizer, Inc.
  • Sai Reddy, Ph.D., Assistant Professor, Biosystems Science & Engineering, ETH Zurich
  • Karen Silence, Ph.D., Research Fellow & Project Manager, ARGX-110, arGEN-X
  • Richie Soong, Ph.D., Research Associate Professor and Senior Principal Investigator, Center for Translational Medicine, National University of Singapore
  • Hao Sun, Ph.D., Assistant Professor, Department of Chemical Pathology; Director, Biomedical Computing Centre, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong
  • Professor Paul Tam, Ph.D., Pro-Vice Chancellor and Vice President, The University of Hong Kong
  • Patrick Boon Ooi TAN, M.D., Ph.D., Associate Research Professor, Institute for Genome Sciences & Policy
  • Vamsi Veeramachaneni, Ph.D., Vice President, Bioinformatics, Strand Life Sciences
  • Gerard Wong, Ph.D., Deputy Director, Investigational Medicine Unit (IMU), National University Health System, Singapore
  • Qi Zeng, Ph.D., Principal Investigator, Institute of Molecular and Cellular Biology, A*STAR
  • Dan Zhang, M.D., MPH, Chairman and CEO, Fountain Medical Development Ltd.
  • Daixing Zhou, Ph.D., CEO, Berry Genomics Co., Ltd.